Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: pharmacology.
作者信息
Oliverio V T
出版信息
Cancer Chemother Rep 3. 1972 May;3(1):69-71.
PMID:4114997
Abstract
摘要
相似文献
1
Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: pharmacology.
Cancer Chemother Rep 3. 1972 May;3(1):69-71.
2
Cell cycle phase specificity and biochemical effects of ellipticine on mammalian cells.玫瑰树碱对哺乳动物细胞的细胞周期阶段特异性及生化效应
Cancer Res. 1972 Nov;32(11):2538-44.
3
Cell cycle phase specificity of antitumor agents.抗肿瘤药物的细胞周期阶段特异性。
Cancer Res. 1972 Feb;32(2):398-407.
4
5
Cell-kill kinetics of several S-phase-specific drugs.几种S期特异性药物的细胞杀伤动力学。
Cancer Res. 1973 Apr;33(4):888-94.
6
7
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
Biochem Pharmacol. 1971 Dec;20(12):3295-308. doi: 10.1016/0006-2952(71)90434-5.
8
9
A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.一种新型抗肿瘤药物：9-羟基玫瑰树碱。在DNA嵌入药物系列中合理设计抗癌药物的可能性。
Proc Natl Acad Sci U S A. 1974 Dec;71(12):5078-82. doi: 10.1073/pnas.71.12.5078.
10
An outline of cancer chemotherapy.
Rev Roum Inframicrobiol. 1971;8(3):135-51.
Zotero 插件